Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04702880 |
|---|---|
| Brief Title: | A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer |
| First Submitted : | January 7, 2021 |
| First Submitted that Met QC Criteria : | January 7, 2021 |
| First Posted : | January 11, 2021 |
| Last Update Submitted that Met QC Criteria : | July 9, 2021 |
| Last Update Posted : | July 12, 2021 |